Cargando…
Underestimated Prediabetic Biomarkers: Are We Blind to Their Strategy?
Type 2 Diabetes (T2D) is currently one of the fastest growing health challenging, a non-communicable disease result of the XXI century lifestyle. Given its growing incidence and prevalence, it became increasingly imperative to develop new technologies and implement new biomarkers for early diagnosis...
Autores principales: | Luís, Carla, Soares, Raquel, Baylina, Pilar, Fernandes, Rúben |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8936175/ https://www.ncbi.nlm.nih.gov/pubmed/35321333 http://dx.doi.org/10.3389/fendo.2022.805837 |
Ejemplares similares
-
Metabolic Dysfunction Biomarkers as Predictors of Early Diabetes
por: Luís, Carla, et al.
Publicado: (2021) -
Does body mass index influence surgical options and overall survival in breast cancer patients?
por: Luís, Carla, et al.
Publicado: (2023) -
A retrospective study in tumour characteristics and clinical outcomes of overweight and obese women with breast cancer
por: Luís, Carla, et al.
Publicado: (2022) -
MicroRNA, Proteins, and Metabolites as Novel Biomarkers for Prediabetes, Diabetes, and Related Complications
por: Vaishya, Suniti, et al.
Publicado: (2018) -
Integrated lipids biomarker of the prediabetes and type 2 diabetes mellitus Chinese patients
por: Yang, Jiaying, et al.
Publicado: (2023)